MedPath

A multicenter clinical study on the effect of Wenyang Huoxue decoction combined with Conventional Cardiac Rehabilitation Technique on the improvement of cardiac function after PCI

Not Applicable
Conditions
Coronary heart disease
Registration Number
ITMCTR2000003801
Lead Sponsor
Shanghai Municipal Hospital of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Patients diagnosed with coronary heart disease who underwent PCI for the first time and were successful 4 weeks postoperatively;
(2) Patients aged 40-75 years;
(3) Low-and medium-risk patients who met the risk stratification for cardiac rehabilitation in coronary heart disease patients;
(4) Syndrome differentiation of Heart Blood Stasis Syndrome, Yang Qi deficiency syndrome;
(5) NYHA Cardiac Energy Classification I-II;
(6) Can cooperate with post-discharge follow-up.

Exclusion Criteria

(1) Direct PCI for acute myocardial infarction occurred within 1 month or within 24 hours in all patients;
(2) Restenosis patients undergoing coronary revascularization;
(3) With heart failure, Cardiogenic shock, severe cardiopulmonary insufficiency, Severe Arrhythmia, etc.;
(4) With other serious diseases of the system: chronic lung disease, malignant tumor, severe primary disease of liver and kidney or mental disease;
(5) The patient is unable to move or refuses to cooperate.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Six-minute walking test;Cardiac function;Cardiorespiratory function;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath